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Virus-induced type I interferon deteriorates control of systemic
pseudomonas aeruginosa infection
Merches, Katja; Khairnar, Vishal; Knuschke, Torben; et al
Abstract: BACKGROUND: Type I interferon (IFN-I) predisposes to bacterial superinfections, an impor-
tant problem during viral infection or treatment with interferon-alpha (IFN-￿). IFN-I-induced neutropenia
is one reason for the impaired bacterial control; however there is evidence that more frequent bacterial
infections during IFN-￿-treatment occur independently of neutropenia. METHODS: We analyzed in a
mouse model, whether Pseudomonas aeruginosa control is influenced by co-infection with the lympho-
cytic choriomeningitis virus (LCMV). Bacterial titers, numbers of neutrophils and the gene-expression of
liver-lysozyme-2 were determined during a 24 hours systemic infection with P. aeruginosa in wild-type
and Ifnar(-/-) mice under the influence of LCMV or poly(I:C). RESULTS: Virus-induced IFN-I impaired
the control of Pseudomonas aeruginosa. This was associated with neutropenia and loss of lysozyme-2-
expression in the liver, which had captured P. aeruginosa. A lower release of IFN-I by poly(I:C)-injection
also impaired the bacterial control in the liver and reduced the expression of liver-lysozyme-2. Low con-
centration of IFN-I after infection with a virulent strain of P. aeruginosa alone impaired the bacterial
control and reduced lysozyme-2-expression in the liver as well. CONCLUSION: We found that during
systemic infection with P. aeruginosa Kupffer cells quickly controlled the bacteria in cooperation with
neutrophils. Upon LCMV-infection this cooperation was disturbed.
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Abstract 
Background: Type I interferon (IFN-I) predisposes to bacterial superinfections, an important 
SUREOHPGXULQJYLUDOLQIHFWLRQRUWUHDWPHQWZLWKLQWHUIHURQDOSKD,)1į,)1,LQGXFHGQHX-
tropenia is one reason for the impaired bacterial control; however there is evidence that more 
IUHTXHQW EDFWHULDO LQIHFWLRQV GXULQJ ,)1įWUHDWPHQW RFFXU LQGHSHQGHQWO\ RI QHXWURSHQLD
Methods: We analyzed in a mouse model, whether Pseudomonas aeruginosa control is in-
ÁXHQFHGE\FRLQIHFWLRQZLWKWKHO\PSKRF\WLFFKRULRPHQLQJLWLVYLUXV/&09%DFWHULDOWLWHUV
numbers of neutrophils and the gene-expression of liver-lysozyme-2 were determined during 
a 24 hours systemic infection with P. aeruginosa in wild-type and Ifnar–/–PLFHXQGHUWKHLQÁX-
ence of LCMV or poly(I:C). Results: Virus-induced IFN-I impaired the control of Pseudomonas 
aeruginosa. This was associated with neutropenia and loss of lysozyme-2-expression in the 
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liver, which had captured P. aeruginosa. A lower release of IFN-I by poly(I:C)-injection also 
impaired the bacterial control in the liver and reduced the expression of liver-lysozyme-2. Low 
concentration of IFN-I after infection with a virulent strain of P. aeruginosa alone impaired 
the bacterial control and reduced lysozyme-2-expression in the liver as well. Conclusion: We 
found that during systemic infection with P. aeruginosa Kupffer cells quickly controlled the bac-
teria in cooperation with neutrophils. Upon LCMV-infection this cooperation was disturbed.
Introduction
Viral infection often predisposes to bacterial superinfection. This has been attributed 
to the reduction of granulocyte-numbers (neutropenia) triggered by high IFN-I-levels 
      ȏͳȐǤ    	ǦȽʹ    
ȏʹǡ͵ȐǤ




   	ǦȽǦ   
control of bacteria.
Pseudomonas aeruginosa ǡǦȏʹȐǡ
which accounts for approximately 10 % of clinical infections and carries a high mortality 
rate [7]. This ubiquitous and predominantly extracellularly living bacterium is a facultative 
        Ǥ ǡ  
    ǡ    ȋ ϐ
ȌȏͺȐ,     ȏͻȐǡ 
ǡǡϐP. aeruginosa-infections can develop 
ǦȏͳͲǦͳʹȐ.
ǡϐǤǡ
(granulocytes) are necessary for control of respiratory P. aeruginosa-ȏͳ͵ǡͳͶȐ. For 




ǦǡȏͳͷȐǤLysozyme-2 –/– mice 
were disabled to clear P. aeruginosaȏͳ͸ȐǡǦ
mice were protected against a respiratory infection with P. aeruginosa [17]. Treatment 
with human lysozyme could reduce the bacterial burden in lungs during a respiratory P. 
aeruginosaȏͳͺȐ.ȏͳͷȐǡ
bronchial epithelial cells [17] and can be induced in hepatocytes [19].
In order to examine further IFN-I induced mechanisms impairing the innate immune 
defense against P. aeruginosa  ϐ      
macrophages in the systemic P. aeruginosa-infection and then compared different inducers 
 	Ǧ   ϐ ǡ
 ǦʹǦ   Ǧ  Ifnar –/– mice. We found that 
neutrophils are essential to clear the bacterium after it has been taken up by macrophages 
Ǥ	ǦǡǦ
ȋȌǡǦʹǦǤ
Lower levels of IFN-I released by poly(I:C)-treatment or the bacterial infection itself had no 
ǡǦǦǦʹǤ
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ͷ͹Ȁ͸ǤIfnar –/–ȏʹͲȐ. Male and female 
͸ͺǦǦǤ
ʹέͳͲ͸	Ǧǯϐǯ




days before infection with P. aeruginosa ȋǦʹȌǤʹͲͲρȋǣȌͳͲͲρ
ǤͳͲͲρǦ
ʹͶȏʹͳȐ.




were considered dead by disease in the survival analysis. 
Determination of P. aeruginosa CFUs
ͳȋȌͷ
ʹͷ-1Ǥǡ͸Ͳρ͵͵ͳͲͲͲ
     ͸Ǧ      Ǥ  ͳͷǦʹͲ 
͵͹ιǡǤ
Antipseudomonal activity assay
ʹͷǤͲͲͲ	ȀǦǦ P. aeruginosa ͶͳͲͳ͹ͷρ
 ȋͳ͸͸͹ǡ 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   Ǧ  ȋǦǡ Ǥ Ͷͷͺ͵ǡ Ȍ  
Ǧ	ͶȀͺͲǦȋǡͳʹǦͶͺͲͳȌǡǦ	ͶȀͺͲǦȋǡͳ͹ǦͶͺͲͳȌǡǦ	ͶȀͺͲǦTMͶͺͺȋ
ǡ ͸ͲͲǦͶͲͶ
Ȍ Ǧ͸Ǧ ȋǡ ͳ͹Ǧͷͻ͵ʹȌǡ Ǧ͸
Ǧ	 ȋͳͳǦͷͻ͵ͳȌǡ Ǧ͸
Ǧ	͸͸Ͳ
ȋǡ ͷͳǦͷͻ͵ͳȌǡ ǦP. aeruginosa ȋǡ ͸ͺͷ͵ͺȌǡ ǦǦ͵ ȋǡ ͳͳͳǦͳ͸ͷǦͳͶͶȌ  Ǧ
ǦTMͷͻͶ ȋ ϐǡ ͵ͷͷ͸ͳȌ Ǥ  ǡ  ϐ ǡ






Enzyme-linked immunosorbent Assay (ELISA)





	           
ȋǡǤͳͷͷͻ͸ͲͳͺȌǤǡ


















         ǲ ò ǡ  
 Ǧǳ ȋȌǡ 
 ȋ ǣ ͺͶǦͲʹǤͲͶǤʹͲͳ͵ǤʹͶʹǡ
ͺͶǦͲʹǤͲͶǤʹͲͳ͵ǤʹͳͺȌ with the German laws for animal protection and with the institutional 
Ǥ
      ǡ ǡ 
      ǡ




To get insight into the processes after intravenous infection with Pseudomonas 
aeruginosa  ϐ         
granulocytes in liver and spleen.
ǡP. aeruginosa from the 
ǡP. aeruginosaͳͲ͵ȏʹ͵ǡʹͶȐǤ
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compared to the liver in its uptake capacity. First we assessed the distribution of P. aeruginosa 
relatively to macrophages and granulocytes in histological sections of liver and spleen one 




ͳͺΨ  P. aeruginosa        ȋ ͳȌǤ 
ϐ͵Ǧȋ	ǤͳȌǤ











Moreover the macrophage-depletion resulted in elevated P. aeruginosa titers in the 
ȋ	ǤͳǡͳȌǤ





To address the importance of granulocytes and macrophages for the control of the 




In this experiment the number of liver granulocytes correlated inversely with the liver-








   ʹͶ  P. aeruginosaǦ ȋ	Ǥ ͳ
Ȍǡ  
approximately 40 % of the induction was measured in granulocyte-depleted mice (Fig. 
Table 1. P. aeruginosa distribution in liver and spleen 1 hour post infection. The proportion of bacteria 
 ȋǤǢ	ͶȀͺͲ+Ȍǡ  ȋ͸
+) or free (not interacting) bacteria were 
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partially granulocyte-dependent induced in the liver after a systemic P. aeruginosa-infection.
Virus-induced IFN-I limits the control of P. aeruginosa, creates neutropenia and blunts the 
expression of lysozyme-II in the liver
To study the effect of viral infection on the innate immune defense against P. aeruginosaǡ
ǦǦʹέͳͲ͸Ǧ ȋ	Ȍȋ
ȌʹͶͶέͳͲ7	P. aeruginosa. The combination of viral 
	ǦȽʹͶǡ
	ǦȽȋ	ǤʹȌǤ
To determine whether virus-induced IFN-I affects the control of P. aeruginosa, we in-










ȋ	ǤʹȌǤ	ǦǦIfnar –/– mice showed that this reduction 
ʹͶ	ǦǦȋ	ǤʹȌǤ
Ǧ	ǦǦ
measured in spleen and blood (data not shown).
Ǧ ǦʹǦ Ǧ
type but not in Ifnar –/– ȋ	Ǥʹ	ȌǤ








ͶǢʹ ǦǣǤǤȌȋȌP. aeruginosa counts in liver and spleen of macrophage-depleted (clodronate-lipo-
ȌȋǦȌǦǡϐ
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Fig. 2. Virus-induced type I interferon limited the control of P. aeruginosa. ȋȌ	ǦȽǦ
ǦʹͶan intravenous P. aeruginosaǦȋʹέͳͲ7	Ȍ
ʹͶǦȋʹέͳͲ͸	Ȍǡȋα͵ȌǤȋȌ ǦȋȌ
Ifnar –/– mice infected intravenously with P. aeruginosaȋͶέͳͲ7	ȌʹͶ
ʹ έͳͲ͸	Ǧȋα͸ǢǦǦǡpδͲǤͲͲͳȌǤȋȌP. aeruginosa titers in organs 







type (WT) or Ifnar –/– ʹέͳͲ7	P. aeruginosa for 1 h with or without 
ʹͶǦȋʹέͳͲ͸	Ȍǡ͸
+͸intȋǡǢαͷǦ͸
 ǢǦȋαͲǤͲͳͷȌǡ ǯ  
Ȍȋ	ȌǦʹȋʹȌʹͶʹέͳͲ7	
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Poly(I:C) limits the control of P. aeruginosa and reduces the expression of lysozyme-2 in 
the liver
ǡ͵Ǧ
such as poly(I:C) could impair the control of P. aeruginosa in wild-type mice. The poly(I:C)-
Ǧ	ǦȽǦͳͲͲͲȀ
P. aeruginosa-ȋͳʹȋǣȌǦȌǡ	ǦȽ-
ʹ Ͷȋ	Ǥ͵ ȌǤ	ǦȽ, compared to the 
ȋͶͲͲͲȀǡ	ǤʹȌǡP. aeruginosa 







phil-numbers in the liver.
Type I interferon induction by virulent P. aeruginosa contributes to pathogenicity
	ǦǡP. aeruginosa ǡ
can have a deteriorating effect on the bacterial clearance as well. Therefore we included 
the more virulent strain P. aeruginosa 	Ͷ͸ͻǤ
in patients and was previously determined to be highly virulent in an acute murine airway 
ȏʹͷȐ.



































   
   




















Cell Physiol Biochem 2015;36:2379-2392
DOI: 10.1159/000430200
Published online: July 27, 2015
© 2015 S. Karger AG, Basel
www.karger.com/cpb 2388
Merches et al.: Type I Interferon Blunts Pseudomonas Aeruginosa Control
Cellular Physiology 
and Biochemistry
Fig. 4. The impact of bacteria-induced IFN-I on the innate immune defense against P. aeruginosa. ȋȌ-






ȋαͳȌǢ	Ͷ͸ͻͶͳͷͲͳǣαͺǢǣαͶǡǡͶͳͷͲͳǣα͵ȋǡȌP. aeruginosa titers in 
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 	ǦȽ   ȋ ȌǤ 
ͶͳͷͲͳȋͶͳͲ7	Ȍ	Ͷ͸ͻȋͳǤ͵ͳͲ7	ȌIfnar 
–/– ǡ	ǦʹͶǤ
Ifnar –/–  	Ͷ͸ͻǡǦȋ	ǤͶȌǤ




Ǧ ǦǦʹ͵Ǧ  Ifnar –/–  mice 
compared to wild-type mice (Fig. 4F).
Taken together these data show that IFN-I-signaling during infection with a virulent 
strain of P. aeruginosa can be detrimental for bacterial clearance and can lead to weaker 
ǦʹǤ
Discussion
In this study we characterized the role of neutrophils and macrophages in mechanisms 
performing systemic clearance of Pseudomonas aeruginosa. The results show that 
neutrophils play a critical role in the elimination of P. aeruginosaǡϐ
            ʹͶ
Ǥǡ
ǡ     Ǥ  
internalization of P. aeruginosaǤ
described in an in vitroȏʹ͸Ȑ. The depletion of macrophages caused 
impaired P. aeruginosa-Ǥ ǡ        
ϐǤǦ
ǡǦȏʹ͹Ȑ. The gene-expression 
ǦǦʹ




Further we analyzed the effects of IFN-I induced by different stimulators on the 
antibacterial defense during the systemic P. aeruginosa-infection. We found that a high 
systemic concentration of IFN-I induced by LCMV pre-infection conferred a severe outcome 
of the systemic P. aeruginosa-infection and limited the number of granulocytes in the liver. In 




   ȏ͵ʹȐ     	Ǧ   
could contribute to an uncontrolled P. aeruginosa infection. Hepatitis C and B patients 
	Ǧȏ͵͵Ȑ. The concentration of 
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Ǧ    Ǧ ȏ͵͸Ȑ.     








but therefore protein levels of IFN-I in the liver should be compared. P. aeruginosa induces 
	ǦǦͶǦ	ȏ͵ͺȐϐ	ͳȏ͵ͻȐ. 
ͶͳͷͲͳȏͶͲȐǤ
of the genomes could give additional hints for the cause of potential differences in IFN-I 
signaling.
Lysozyme-chloride has already reached clinical attention. The here described association 
between reduced lysozyme-expression and the course of P. aeruginosa-infection suggests 
that a treatment with human lysozyme could compensate the loss of endogenous lysozyme-
production and thereby improve the outcome of P. aeruginosa bloodstream-infections in 
patients.
 ǡ       ϐP. aeruginosa 
during a systemic infection and the cooperation with granulocytes as essential for the control 
of the bacteria. Furthermore we found that the induction of high systemic levels of IFN-I by 
LCMV exacerbate P. aeruginosa ǡ 
ǦǦǦʹǤ	Ǧ
induced by poly(I:C) or the bacterial infection itself impair the clearance of P. aeruginosa in 
Ǧ ǦʹǤϐ
understand processes that occur in lethal infections with P. aeruginosa.
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